1010104-34-3

Basic information

• Product Name: Pyridine, 3-(2-Methoxyethoxy)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-
• Synonyms: Pyridine, 3-(2-Methoxyethoxy)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-
• CAS NO: 1010104-34-3
• Molecular Formula: C14H22BNO4
• Molecular Weight: 279.13978
• Mol File: 1010104-34-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Pyridine, 3-(2-Methoxyethoxy)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine, 3-(2-Methoxyethoxy)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-(1010104-34-3)
• EPA Substance Registry System: Pyridine, 3-(2-Methoxyethoxy)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-(1010104-34-3)

Safety Data

• Hazardous Substances Data: 1010104-34-3(Hazardous Substances Data)

Upstream product

• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 181585-07-9 3-bromo-5-(2-methoxyethoxy)pyridine 
• 73183-34-3 bis(pinacol)diborane 

Relevant articles and documents

Highly fluorescent M2L4 molecular capsules with anthracene shells

M2L4 molecular capsules self-assembled from M(ii) ions (where M = Zn, Ni, and Pd) and bent bidentate ligands constructed from anthracene fluorophores. The Ni(ii) and Zn(ii) capsules exhibited weak to strong blue emission unlike traditional Pd(ii) cages and capsules. The Royal Society of Chemistry 2011.

1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to the use of 1 H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1 H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1 H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1 H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1 H-imidazo[4,5-c]quinolinone compounds.

PYRROLE DERIVATIVES USEFUL FOR THE TREATMENT OF CYTOKINE-MEDIATED DISEASES

A compound of Formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the groups R1-R6 and A are as defined in the specification.